Literature DB >> 12014534

Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.

Stephen Morgan1, David Mant.   

Abstract

BACKGROUND: Atrial fibrillation is a common and treatable cause of stroke that often remains unrecognised. Screening has been suggested but there is very little evidence concerning the uptake of screening in the elderly population at risk, nor of the optimal method of screening in a general practice setting AIM: To compare the uptake and effectiveness of two methods of screening for atrial fibrillation in general practice--systematic nurse-led screening and prompted opportunistic case finding. DESIGN OF STUDY: Randomised controlled trial.
SETTING: Patients aged 65 to 100 years (n = 3,001) from four general practices within the MRC general practice framework.
METHOD: Each of the four study practices were selected from one quartile, after ranking all framework practices according to the small area standardised mortality ratio of the geographical area served. Patients were randomised either to nurse-led screening or to prompted opportunistic casefinding. The proportion of patients assessed and the proportion found to have atrial fibrillation were compared. The sensitivity and specificity of clinical assessment of pulse are also reported.
RESULTS: Substantially more patients had their pulse assessed through systematic screening by invitation (1,099/1,499 [73%]) than through opportunistic case finding (439/1,502 [29%], difference = 44%, 95% confidence interval [CI] = 41% to 47%). Atrial fibrillation was detected in 67 (4.5%) and 19 (1.3%) patients respectively (difference = 3.2%, 95% CI= 2.0 to 4.4). Invitation to nurse-led screening achieved significantly higher assessment rates than case finding in all practices; however, the proportion of patients assessed in the case-finding arm varied markedly between practices (range = 8% to 52%). The number needed to screen to identify one additional patient with atrial fibrillation was 31 (95% CI = 23 to 50). The proportion of screened patients with atrial fibrillation receiving anticoagulation treatment was 25%, although in the majority (53/65 [82%]) atrial fibrillation had been previously recorded somewhere on their medical record. If the nurse used any irregularity of the pulse as the screening criterion, the sensitivity of screening was 91% and the specificity was 74%; sensitivity fell to 54% but specificity increased to 98% if the criterion used was continuous irregularity.
CONCLUSIONS: Nurse-led screening for atrial fibrillation in UK general practice is both feasible and effective and will identify a substantial number of patients who could benefit from antithrombotic therapy. Although the majority of patients detected at first screening could be identified by careful scrutiny of medical records, review of record summaries was insufficient in the practices involved in this study and screening may be a more cost-effective option.

Entities:  

Mesh:

Year:  2002        PMID: 12014534      PMCID: PMC1314292     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  12 in total

Review 1.  Consultation rates in English general practice.

Authors:  D M Fleming
Journal:  J R Coll Gen Pract       Date:  1989-02

2.  Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.

Authors:  H Rodgers; M Sudlow; R Dobson; R A Kenny; R G Thomson
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

Review 3.  ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation.

Authors:  G Y Lip; D G Beevers
Journal:  BMJ       Date:  1995-11-18

4.  Service provision and use of anticoagulants in atrial fibrillation.

Authors:  C M Sudlow; H Rodgers; R A Kenny; R G Thomson
Journal:  BMJ       Date:  1995-08-26

5.  Warfarin in chronic atrial fibrillation.

Authors:  L E Ramsay
Journal:  Lancet       Date:  1993-05-29       Impact factor: 79.321

6.  Atrial fibrillation: a comparison of methods to identify cases in general practice.

Authors:  S Somerville; J Somerville; P Croft; M Lewis
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

7.  Screening for atrial fibrillation in primary care.

Authors:  N M Wheeldon; D I Tayler; E Anagnostou; D Cook; C Wales; G D Oakley
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

8.  The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Authors:  T R Lancaster; D E Singer; M A Sheehan; L B Oertel; S W Maraventano; R A Hughes; J P Kistler
Journal:  Arch Intern Med       Date:  1991-10

9.  Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.

Authors:  B F Gage; A B Cardinalli; G W Albers; D K Owens
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

10.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

View more
  28 in total

Review 1.  Population-Based Screening for Atrial Fibrillation.

Authors:  Shaan Khurshid; Jeffrey S Healey; William F McIntyre; Steven A Lubitz
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.

Authors:  David A Fitzmaurice; F D Richard Hobbs; Sue Jowett; Jonathon Mant; Ellen T Murray; Roger Holder; J P Raftery; S Bryan; Michael Davies; Gregory Y H Lip; T F Allan
Journal:  BMJ       Date:  2007-08-02

Review 3.  Management of atrial fibrillation.

Authors:  Gregory Y H Lip; Antonio Tello-Montoliu
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

Review 4.  Identification, diagnosis and assessment of atrial fibrillation.

Authors:  R I Dewar; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

5.  Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.

Authors:  Femke Kaasenbrood; Monika Hollander; Steven Hm de Bruijn; Carlijn Pe Dolmans; Robert G Tieleman; Arno W Hoes; Frans H Rutten
Journal:  Br J Gen Pract       Date:  2020-05-28       Impact factor: 5.386

6.  Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach.

Authors:  Rachel E Jordan; Kin-bong Hubert Lam; Kar Keung Cheng; Martin R Miller; Jennifer L Marsh; Jon G Ayres; David Fitzmaurice; Peymané Adab
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

7.  Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial.

Authors:  Jeffrey M Ashburner; Steven J Atlas; David D McManus; Yuchiao Chang; Ana T Trisini Lipsanopoulos; Leila H Borowsky; Wyliena Guan; Wei He; Patrick T Ellinor; Daniel E Singer; Steven A Lubitz
Journal:  Am Heart J       Date:  2019-06-22       Impact factor: 4.749

Review 8.  Systematic screening for the detection of atrial fibrillation.

Authors:  Patrick S Moran; Conor Teljeur; Mairin Ryan; Susan M Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-06-03

Review 9.  Screening for Atrial Fibrillation in Community and Primary CareSettings: A Scoping Review.

Authors:  Emma Canty; Claire MacGilchrist; Wael Tawfick; Caroline McIntosh
Journal:  J Atr Fibrillation       Date:  2021-02-28

10.  Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records.

Authors:  Olivia L Hulme; Shaan Khurshid; Lu-Chen Weng; Christopher D Anderson; Elizabeth Y Wang; Jeffrey M Ashburner; Darae Ko; David D McManus; Emelia J Benjamin; Patrick T Ellinor; Ludovic Trinquart; Steven A Lubitz
Journal:  JACC Clin Electrophysiol       Date:  2019-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.